Aromatase and COX in Breast Cancer: Enzyme Inhibitors and Beyond

Journal of Steroid Biochemistry and Molecular Biology - United Kingdom
doi 10.1016/j.jsbmb.2007.05.021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Use of Aromatase Inhibitors in Breast Carcinoma

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
1999English

CDK4/6 Inhibitors: Promising Opportunities Beyond Breast Cancer

Cancer Discovery
Oncology
2016English

Estrone Sulphate, FSH, and Testosterone Levels in Two Male Breast Cancer Patients Treated With Aromatase Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2010English

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2003English

A Cost-Effectiveness Analysis of Palbociclib and Other Aromatase Inhibitors for Treatment of Advanced Breast Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Prospective Characterization of Musculoskeletal Symptoms in Early Stage Breast Cancer Patients Treated With Aromatase Inhibitors

Breast Cancer Research and Treatment
Cancer ResearchOncology
2007English

Aromatase and Breast Cancer: W39R, an Inactive Protein

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2002English

Review of Hormone-Based Treatments in Postmenopausal Patients With Advanced Breast Cancer Focusing on Aromatase Inhibitors and Fulvestrant

ESMO Open
Cancer ResearchOncology
2016English

Genetic Variants of CYP19 (Aromatase) and Breast Cancer Risk

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy